Robert M. MacGregor, MD

Clinical and research interests include the surgical treatment of atrial fibrillation and other adult cardiac diseases.

Samantha Mackin, MD, PhD

DBBS Pre Doc Trainee

Investigating antibody Fc-mediated mechanisms of protection against SARS-CoV-2.

Susan E. Mackinnon, MD

Sydney M., Jr. and Robert H. Shoenberg Professor of Surgery (Plastic and Reconstructive Surgery)

My clinical/research interest includes over 30 years of experience in the investigation of peripheral nerve injury and regeneration. My clinical practice is solely devoted to the treatment of ...

Chelsea E. Macpherson, DPT, PhD

Postdoc Research Associate

Dr. Macpherson's research focuses on the investigation of methods of exercise and physical activity behavior change across neurodegenerative conditions, their impact on disease specific measures, and ...

Thomas Maddox, MD, MSC

Clinicial interests include general cardiology, coronary artery disease, heart failure, atrial fibrillation, cardiac imaging, and cardiac prevention. Research interests include health services ...

Kamala K. Madireddi, BA

Pre-doc

As a member of the Brogan Lab, I am interested in peripheral nerve injuries, nerve regeneration, and the implication of the SARM-1 gene in this process.

Ju Heon Maeng, PhD

Postdoc Research Associate

Transposable element-derived antigens in glioblastoma as an alternative targets for immunotherapy. Transposable element expression as a potential markers for disease progress in neurodevelopmental ...

Abigail Magee, PhD

I study data registration techniques for optical functional neuroimaging and developing both hardware and algorithms for investigating brain function in acute care scenarios and its relationship to ...

Jeffrey A. Magee, MD, PhD

Elizabeth H and James S McDonnell, III Prof of Pediatric Hematology/Oncology SLCH

We are interested in how blood forming stem cells self-renew and in how these self-renew programs are hijacked to drive leukemia cell proliferation.

Leonard B. Maggi, PhD

Assistant Professor of Medicine

The overall goal of our research is to understand why 96% of human prostate adenocarcinomas lose ARF expression even though they are actively proliferating. We hypothesize that loss of ARF leads to ...